Navigation Links
Arizona Heart Institute Enrolls First Patient in Anaconda(TM) Investigational Study for the Treatment of Abdominal Aortic Aneurysm
Date:6/19/2009

Local Vascular Surgeon Named National Principal Investigator

PHOENIX, June 19 /PRNewswire/ -- Surgeons from Arizona Heart Institute performed the first procedure in the U.S. Anaconda Phase II Study using the Vascutek Anaconda Stent Graft System, an investigational, minimally invasive treatment for abdominal aortic aneurysm (AAA).

Leading the study efforts in the U.S. is Julio Rodriguez-Lopez, M.D., Vascular Surgeon, Arizona Heart Institute and Arizona Heart Hospital, and National Principal Investigator. "The Anaconda Stent Graft System has the potential to treat patients with infrarenal AAAs," said Dr. Rodriguez. "In commercial use outside the U.S. Phase II study, this stent graft has been shown to be flexible and repositionable. These are important features when treating patients with infrarenal AAAs," continued Rodriguez.

Abdominal aortic aneurysm, or "ballooning" of the body's main artery, is a serious condition in which the aorta is prone to rupture often causing sudden death. Studies report that emergent, open surgical repair of a ruptured aortic aneurysm carries a 25 to 50 percent risk of death; however, less invasive endovascular procedures involving stent grafts offer a lower-risk alternative to open surgical repair and are associated with minimal blood loss, faster recovery, shorter hospital stays and decreased risk of death.

"Experience with the device, which has been used commercially in nearly 4000 patients in Europe, has been very positive," said Donald B. Reid, M.D., Fellow of the Royal College of Surgeons, Consultant Vascular Surgeon, and Chairman of Vascular Surgery with Wishaw General Hospital and University of Glasgow, Scotland, U.K., who attended the procedure at Arizona Heart Hospital.

Symptoms of aortic rupture can occur suddenly with severe, sharp pain in the abdomen. Patients who experience these symptoms should seek immediate medical attention. Early detection of aortic aneurysms can prevent sudden death; therefore, patients with a family history of aortic aneurysm or other connective tissue disorders should notify their physician about their risk of aortic aneurysm.

About Arizona Heart Institute

Arizona Heart Institute (AHI) is among the world's leading providers of cardiovascular care and world authority in the endovascular treatment of aortic aneurysm and related pathologies. Founded in 1971, AHI has earned its reputation for excellence by creating a state-of-the-art medical facility that specializes in the prevention, diagnosis and treatment of heart and blood vessel disease. In the 1990s, Dr. Edward B. Diethrich, Founder and Medical Director of Arizona Heart Institute and Arizona Heart Hospital, pioneered the development of the very first stent graft for aortic aneurysms. Since then, this minimally invasive technique has become the gold standard worldwide and has changed the way vascular medicine approaches disorders of the aorta. Through dedication, education and innovation, AHI is leading the effort to eliminate cardiovascular disease and discovering new ways to save lives along the way. For more information, please visit www.azheart.com, or contact mcocco@azheart.com.

About the Study

The objective of the Vascutek Anaconda Stent Graft System Phase II IDE Study (G030036) is to assess the safety and efficacy of the Anaconda Stent Graft System in patients presenting with AAA, when compared to historical open surgical repair. The study, which is sponsored by Terumo Cardiovascular Systems, Ann Arbor, Michigan, is expected to enroll a total of 180 patients at 20 U.S. sites. The device is manufactured by Vascutek Ltd, a Terumo Company located near Glasgow, Scotland. More information can be found at clinicaltrials.gov NCT00612924.


'/>"/>
SOURCE Arizona Heart Institute and Hospital
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
2. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign
3. The Well Life Center in Mesa Unveils The 10 Healing Secrets to Health & Longevity Lecture. Proceeds Benefit The Arizona Special Olympics
4. The Well Life Center in Mesa Continues The 10 Healing Secrets to Health & Longevity Lecture. Proceeds Benefit The Arizona Special Olympics
5. Neptune Society Opens Tucson, Arizona Office
6. Phoenix Fire Chief Bob Khan Encourages Arizonans to Get Vaccinated Against Influenza
7. NNN Healthcare/Office REIT Acquires Tucson Medical Office Portfolio in Tucson, Arizona
8. Arizona Patient Protection Act Introduced
9. Bill Germanakos and Hollie Self Bring The Biggest Loser Million-Pound Tour, Presented by MSN, to Arizona Mills Mall
10. Arizona-Based Healthy Lifestyle Corporate Events Helps Football Fans Commit to Good Health
11. Sharps Compliance Corp. to Present at the RedChip Small-Cap Investor Conference in Scottsdale, Arizona
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... CA (PRWEB) , ... February 27, 2017 , ... ... serving San Francisco and environs, is proud to announce an upgrade to the ... on the upgraded Yelp page on topics as diverse as Platelet Rich Plasma ...
(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home care agency based ... and Palo Alto, is proud to announce an important upgrade to its geographic information ... home care close to home, and by having city-specific pages, NuevaCare is answering that ...
(Date:2/26/2017)... ... February 26, 2017 , ... Functional imaging data supports improved ... study released today at the 1st Pan American Parkinson’s and Movement Disorders Congress. ... effective in improving cognitive function in PD patients. This study, led by Ibarretxe-Bilbao ...
(Date:2/24/2017)... ... 2017 , ... Only two months after the official release of The Private ... (France), XO Private has initiated a second print-run of its lavish luxury travel coffee ... across when open, weighs in at more than six kilos, retails at EUR 1,000 ...
(Date:2/24/2017)... ... ... In the Health Care IT campaign, Robert Herjavec discusses health IT security ... will be attacked, but when.” However, he and many others involved highlight a promising ... in auditing and monitoring have taken security in health care a very long way. ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... , Feb. 27, 2017  Interpace Diagnostics Group, ... provides clinically useful molecular diagnostic tests and pathology services, ... presented at the upcoming United States ... held March 4-10, 2017 in San Antonio, ... a review of data from the Company,s extensive experience ...
(Date:2/27/2017)... Fla. , Feb. 27, 2017 ... focused on developing cerebral embolic protection devices for ... the FDA,s Circulatory System Devices Panel that convened ... need for cerebral protection following transcatheter aortic valve ... by this FDA panel support the need for ...
(Date:2/27/2017)... 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... focused on tissue protection, repair and regeneration, today ... Ltd., received a positive response from the U.S. ... for RGN-137 to treat epidermolysis bullosa ("EB"). RGN-137 ... Thymosin beta 4 ("Tß4") as the active pharmaceutical ...
Breaking Medicine Technology: